Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22IgM%22&type=Subject&filter%5B%5D=collection%3ACTG
/vufind/Search/Results?lookfor=%22IgM%22&type=Subject&filter%5B%5D=collection%3ACTG
Search /vufind/Search2/Results?lookfor=%22IgM%22&type=Subject&filter%5B%5D=collection%3ACTG
PubPharm (26)
1
A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders : Prospective Study of the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies : Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
The analysis about the efficacy of Rituximab against IgM anti-myelin-associated glycoprotein antibody demtelinating neuropathy : The analysis about the efficacy of Rituximab against IgM anti-myelin-associated glycoprotein antibody demtelinating neuropathy - The analysis about the efficacy of Rituximab against IgM anti-myelin-associated glycoprotein antibody demtelinating neuropathy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
4
The analysis about the efficacy of Rituximab against IgM anti-myelin-associated glycoprotein antibody demtelinating neuropathy : The analysis about the efficacy of Rituximab against IgM anti-myelin-associated glycoprotein antibody demtelinating neuropathy - The analysis about the efficacy of Rituximab against IgM anti-myelin-associated glycoprotein antibody demtelinating neuropathy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
5
Detection of MYD88 L265P Mutation By Next Generation Deep Sequencing in Peripheral Blood Mononuclear Cells of Waldenstrom Macroguloblinemia and IgM Monoclonal Gammopathy of Undetermined Significance : Detection of MYD88 L265P Mutation By Next Generation Deep Sequencing in Peripheral Blood Mononuclear Cells of Waldenstrom Macroguloblinemia and IgM Monoclonal Gammopathy of Undetermined Significance - Detection of MYD88 L265P Mutation By Next Generation Deep Sequencing
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
6
The efficacy and safety of rituximab in neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein antibody : The efficacy and safety of rituximab in neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein antibody - Rituximab in neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein antibody
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
7
Detection of MYD88 L265P Mutation By Next Generation Deep Sequencing in Peripheral Blood Mononuclear Cells of Waldenstrom Macroguloblinemia and IgM Monoclonal Gammopathy of Undetermined Significance : Detection of MYD88 L265P Mutation By Next Generation Deep Sequencing in Peripheral Blood Mononuclear Cells of Waldenstrom Macroguloblinemia and IgM Monoclonal Gammopathy of Undetermined Significance - Detection of MYD88 L265P Mutation By Next Generation Deep Sequencing
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
8
The efficacy and safety of rituximab in neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein antibody : The efficacy and safety of rituximab in neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein antibody - Rituximab in neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein antibody
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
9
A MULTICENTER STUDY ON THE EFFICACY, SAFETY AND PHARMACOKINETICS OF I10E IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY (PID) : A MULTICENTER STUDY ON THE EFFICACY, SAFETY AND PHARMACOKINETICS OF I10E IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY (PID)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
10
A MULTICENTER STUDY ON THE EFFICACY, SAFETY AND PHARMACOKINETICS OF I10E IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY (PID) : A MULTICENTER STUDY ON THE EFFICACY, SAFETY AND PHARMACOKINETICS OF I10E IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY (PID)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
26
Aufsätze
26
E-Artikel
26
E-Ressourcen
Zeitschriftentitel
18
WHO International Clinical Trials Registry Plat...
8
ClinicalTrials.gov
Thema
26
610
19
Study Type: Interventional
7
Hyper-IgM Immunodeficiency Syndrome
7
Phase: Phase 3
7
Study Type: Observational
6
Recruitment Status: Complete: follow-up complete
6
Recruitment Status: Completed
6
Recruitment Status: Not yet recruiting
5
Common Variable Immunodeficiency
5
Hyper-IgM Immunodeficiency Syndrome, Type 1
5
Immunologic Deficiency Syndromes
5
Recruitment Status: Recruiting
4
Agammaglobulinemia
4
Phase: Phase 2
3
Syndrome
3
Wiskott-Aldrich Syndrome
2
Medical Condition: Detection of IgG and IgM ant...
2
Medical Condition: Health Condition 1: null- De...
2
Medical Condition: IgM anti-myelin-associated g...
2
Medical Condition: Neuropathy associated with I...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
19
2020-
7
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
26
Englisch
Haven't found what you're looking for?
Wird geladen...